Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0X4NF
|
||||
Former ID |
DIB006451
|
||||
Drug Name |
Radiosensitizer gene therapy
|
||||
Synonyms |
Radiosensitizer gene therapy (prostate cancer)
|
||||
Indication | Pancreatic cancer [ICD9: 140-199, 140-229, 157, 210-229; ICD10:C25] | Phase 3 | [550209] | ||
Company |
Advantagene
|
||||
Target and Pathway | |||||
Target(s) | Thymidine kinase | Target Info | Inhibitor | [534746] | |
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.